Search

LOS ANGELES COURT REJECTS PATRICK SOON-SHIONG'S ATTEMPT TO AVOID SORRENTO LITIGATION ALLOWING ARBITRATION CASE TO MOVE FORWARD

SAN DIEGO, Oct. 15, 2019 - Sorrento Therapeutics, Inc. announced today that a Los Angeles Superior Court judge has rejected Patrick...

NEUROCRINE BIOSCIENCES ANNOUNCES CONFERENCE CALL AND WEBCAST OF THIRD QUARTER 2019 FINANCIAL RESULTS

Conference Call and Webcast Scheduled for Monday, November 4 SAN DIEGO, Oct. 14, 2019 /PRNewswire/ - Neurocrine Biosciences, Inc. announced...

 
 
 

MEDICINOVA RECEIVES NOTICE OF ALLOWANCE FOR NEW PATENT COVERING MN-001 AND MN-002 FOR THE TREATMENT OF IDIOPATHIC PULMONARY FIBROSIS IN JAPAN

LA JOLLA, Calif., Oct. 07, 2019 - MediciNova, Inc., a biopharmaceutical company traded on the NASDAQ Global Market and the JASDAQ Market...

SORRENTO THERAPEUTICS ANNOUNCES $25 MILLION REGISTERED DIRECT OFFERING

SAN DIEGO, Oct. 07, 2019 - Sorrento Therapeutics, Inc. , a clinical stage, antibody-centric biopharmaceutical company developing new...

 
 
 

OBALON ANNOUNCES REPAYMENT OF ALL LONG-TERM DEBT AND REGAINING OF COMPLIANCE WITH NASDAQ LISTING REQUIREMENT

SAN DIEGO, Oct. 03, 2019 - Obalon Therapeutics, Inc. , a San Diego-based company focused on commercializing the Obalon Balloon System,...

ANAPTYSBIO REPORTS POSITIVE TOPLINE DATA FROM INTERIM ANALYSIS OF GALLOP PHASE 2 CLINICAL TRIAL OF ANB019 MONOTHERAPY IN MODERATE-TO-SEVERE GENERALIZED PUSTULAR PSORIASIS

SAN DIEGO, Sept. 30, 2019 - AnaptysBio, Inc. , a clinical-stage biotechnology company developing first-in-class antibody product candidates...

 
 
 

MEDICINOVA RECEIVES NOTICE OF ALLOWANCE FOR NEW PATENT COVERING MN-001 FOR THE TREATMENT OF IDIOPATHIC PULMONARY FIBROSIS IN CHINA

LA JOLLA, Calif., Sept. 30, 2019 - MediciNova, Inc., a biopharmaceutical company traded on the NASDAQ Global Market and the JASDAQ...

ANAPTYSBIO TO PRESENT AT THE CANTOR FITZGERALD GLOBAL HEALTHCARE CONFERENCE

SAN DIEGO, Sept. 27, 2019 - AnaptysBio, Inc. , a clinical-stage biotechnology company developing first-in-class antibody product candidates...

 
 
 
Peloton wipes out more than $900 million of investor wealth in its 1st day of public trading

PELOTON WIPES OUT MORE THAN $900 MILLION OF INVESTOR WEALTH IN ITS 1ST DAY OF PUBLIC TRADING

Peloton erased more than $900 million in investor capital Thursday after its initial public offering on the Nasdaq. The company's stock...

 
 
 
‘We are seeing volume and interest in Peloton explode,' says company president on listing day

‘WE ARE SEEING VOLUME AND INTEREST IN PELOTON EXPLODE,' SAYS COMPANY PRESIDENT ON LISTING DAY

This morning, Peloton , the tech-enabled stationary bicycle and fitness content streaming company, raised $1.2 billion in its NASDAQ...

5 Easy Ways to Jump-Start Your Freelance Career

5 EASY WAYS TO JUMP-START YOUR FREELANCE CAREER

Are you interested in starting a freelance career? Freelancing has been on the rise in recent years and it's only going to keep growing....

 
 
 
Google and other FAANG stocks saw $58 billion wiped out after Trump slammed the 'immense power' of big tech

GOOGLE AND OTHER FAANG STOCKS SAW $58 BILLION WIPED OUT AFTER TRUMP SLAMMED THE 'IMMENSE POWER' OF BIG TECH

Trump's speech to the UN on Tuesday cost the world's biggest tech companies billions in value. The FAANGs (Facebook, Amazon, Apple,...

SYNTHORX TO PRESENT AT THE EUROPEAN SOCIETY FOR MEDICAL ONCOLOGY 2019 CONGRESS

SAN DIEGO, Sept. 23, 2019 - Synthorx, Inc. , a clinical-stage biotechnology company developing optimized therapeutics for cancer and...

 
 
 
Stocks slide as China cancels US farmer visit

STOCKS SLIDE AS CHINA CANCELS US FARMER VISIT

Stocks traded lower on Friday after the Chinese trade delegation canceled a trip to US farms next week. The visit was seen as a gesture...

Cracker Barrel Celebrates 50 Years as America's Home-Away-From-Home

CRACKER BARREL CELEBRATES 50 YEARS AS AMERICA'S HOME-AWAY-FROM-HOME

Brand launches CrackerBarrelMoment social campaign to commemorate half a century of Pleasing People Lebanon, TN Fifty years ago today,...

 
 
 

ARTELO BIOSCIENCES CANNABIDIOL STUDIES REFERENCED IN SEPTEMBER ISSUE OF NATURE MEDICINE

LA JOLLA, Calif., Sept. 18, 2019 - Artelo Biosciences, Inc. , a clinical stage biopharmaceutical company developing therapeutics that...

INMUNE BIO INVITED TO SPEAK ON COMPANY'S ADVANCEMENTS IN CANCER TREATMENTS AT THE TARGETING INNATE IMMUNITY CONGRESS AND MARKETSANDMARKETS NEXT GEN IMMUNO-ONCOLOGY CONGRESS

La Jolla, CA., Sept. 17, 2019 - INmune Bio, Inc. , an immunology company focused on developing treatments that harness the patient's...

 
 
 

EQUILLIUM TO HOST BUSINESS UPDATE CALL ON OCTOBER 1, 2019

LA JOLLA, Calif., Sept. 17, 2019 - Equillium, Inc. , a clinical-stage biotechnology company, leveraging deep understanding of immunobiology...

Stocks close mixed as the Dow gains for the 8th day in a row

STOCKS CLOSE MIXED AS THE DOW GAINS FOR THE 8TH DAY IN A ROW

Stocks finished mixed on Friday as the Dow Jones industrial average rose for the eighth day in a row. The S&P 500 index was relatively...